This week brings encouraging news: Johnson & Johnson’s one-dose COVID-19 vaccine has become the third COVID-19 vaccine given Emergency Use Authorization by the U.S. Food and Drug Administration (FDA).
What’s more, the Johnson & Johnson vaccine requires only one dose, which will help speed-up the vaccination process.
Here are Four Things to Know About the Johnson & Johnson COVID-19 Vaccine:
- The U.S. Food and Drug Administration (FDA) has now approved three COVID-19 vaccines for Emergency Use Authorization (EUA). It is the first single-dose vaccine approved for EUA.
- Johnson & Johnson’s single-dose vaccine uses a harmless adenovirus to activate an immune response to the coronavirus spike protein. It shows mild side effects like other vaccines.
- Clinical trials showed it is 72 percent effective against COVID-19 infection and 86 percent effective against severe illness and death in those who received the vaccine. No COVID-19 deaths were reported in those vaccinated during clinical trials.
- It doesn’t matter which vaccine you receive. The most important thing is to get vaccinated when it is your turn. Vaccination is the most effective way to end the COVID-19 pandemic and protect yourself and those you come in contact with.
It’s still important, however, to continue wearing a mask, washing your hands often, avoiding crowds and staying at least 6 feet away from others.
Together we can end the pandemic!